163 related articles for article (PubMed ID: 23215758)
1. Effects of etravirine on the pharmacokinetics and pharmacodynamics of warfarin in rats.
John J; John M; Wu L; Hsiao C; Abobo CV; Liang D
Br J Pharmacol; 2013 Apr; 168(8):1851-8. PubMed ID: 23215758
[TBL] [Abstract][Full Text] [Related]
2. Effect of eslicarbazepine acetate on the steady-state pharmacokinetics and pharmacodynamics of warfarin in healthy subjects during a three-stage, open-label, multiple-dose, single-period study.
Vaz-da-Silva M; Almeida L; Falcão A; Soares E; Maia J; Nunes T; Soares-da-Silva P
Clin Ther; 2010 Jan; 32(1):179-92. PubMed ID: 20171423
[TBL] [Abstract][Full Text] [Related]
3. Effects of cucurbitacin e, a tetracyclic triterpene compound from Cucurbitaceae, on the pharmacokinetics and pharmacodynamics of warfarin in rats.
Ding T; Zhang Y; Chen A; Tang Y; Liu M; Wang X
Basic Clin Pharmacol Toxicol; 2015 May; 116(5):385-9. PubMed ID: 25250504
[TBL] [Abstract][Full Text] [Related]
4. Responsiveness to low-dose warfarin associated with genetic variants of VKORC1, CYP2C9, CYP2C19, and CYP4F2 in an Indonesian population.
Rusdiana T; Araki T; Nakamura T; Subarnas A; Yamamoto K
Eur J Clin Pharmacol; 2013 Mar; 69(3):395-405. PubMed ID: 22855348
[TBL] [Abstract][Full Text] [Related]
5. Effects of folic acid supplementation on the pharmacokinetics and anticoagulant effect of warfarin: an open-label, prospective study of long-term administration in adults.
Muszkat M; Bialer O; Blotnick S; Adar L; Xie HG; Ufer M; Cascorbi I; Caraco Y
Clin Ther; 2010 Feb; 32(2):347-56. PubMed ID: 20206792
[TBL] [Abstract][Full Text] [Related]
6. A pilot study of the association of pharmacokinetic and pharmacodynamic parameters of warfarin with the dose in patients on long-term anticoagulation.
Kulkarni UP; Swar BD; Karnad DR; Davis S; Patwardhan AM; Kshirsagar NA; Gogtay NJ
Br J Clin Pharmacol; 2008 May; 65(5):787-90. PubMed ID: 18294321
[TBL] [Abstract][Full Text] [Related]
7. Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects.
Jiang X; Williams KM; Liauw WS; Ammit AJ; Roufogalis BD; Duke CC; Day RO; McLachlan AJ
Br J Clin Pharmacol; 2004 May; 57(5):592-9. PubMed ID: 15089812
[TBL] [Abstract][Full Text] [Related]
8. Effect of rutin on warfarin anticoagulation and pharmacokinetics of warfarin enantiomers in rats.
Chan E; Hegde A; Chen X
J Pharm Pharmacol; 2009 Apr; 61(4):451-8. PubMed ID: 19298691
[TBL] [Abstract][Full Text] [Related]
9. The pharmacokinetics and pharmacodynamics of warfarin in combination with ambrisentan in healthy volunteers.
Walker G; Mandagere A; Dufton C; Venitz J
Br J Clin Pharmacol; 2009 May; 67(5):527-34. PubMed ID: 19552747
[TBL] [Abstract][Full Text] [Related]
10. Determination of unbound warfarin enantiomers in human plasma and 7-hydroxywarfarin in human urine by chiral stationary-phase liquid chromatography with ultraviolet or fluorescence and on-line circular dichroism detection.
Takahashi H; Kashima T; Kimura S; Muramoto N; Nakahata H; Kubo S; Shimoyama Y; Kajiwara M; Echizen H
J Chromatogr B Biomed Sci Appl; 1997 Nov; 701(1):71-80. PubMed ID: 9389340
[TBL] [Abstract][Full Text] [Related]
11. Effect of 5-fluorouracil on the anticoagulant activity and the pharmacokinetics of warfarin enantiomers in rats.
Zhou Q; Chan E
Eur J Pharm Sci; 2002 Oct; 17(1-2):73-80. PubMed ID: 12356422
[TBL] [Abstract][Full Text] [Related]
12. Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects.
Jiang X; Williams KM; Liauw WS; Ammit AJ; Roufogalis BD; Duke CC; Day RO; McLachlan AJ
Br J Clin Pharmacol; 2005 Apr; 59(4):425-32. PubMed ID: 15801937
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and pharmacodynamics of tecarfarin, a novel vitamin K antagonist oral anticoagulant.
Albrecht D; Ellis D; Canafax DM; Combs D; Druzgala P; Milner PG; Midei MG
Thromb Haemost; 2017 Apr; 117(4):706-717. PubMed ID: 28180234
[TBL] [Abstract][Full Text] [Related]
14. Effect of nebicapone on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects.
Almeida L; Falcão A; Vaz-da-Silva M; Nunes T; Santos AT; Rocha JF; Neta C; Macedo T; Fontes-Ribeiro C; Soares-da-Silva P
Eur J Clin Pharmacol; 2008 Oct; 64(10):961-6. PubMed ID: 18679669
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous determination of warfarin and 7-hydroxywarfarin in rat plasma by HPLC-FLD.
Zayed A; Babaresh WM; Darweesh RS; El-Elimat T
Acta Pharm; 2020 Sep; 70(3):343-357. PubMed ID: 32074068
[TBL] [Abstract][Full Text] [Related]
16. [Effect of Shuxuetong injection on anticoagulant effect of warfarin in rats].
Zhao HF; Sun JH; Liu S; Liu Y; Liu GF
Zhongguo Zhong Yao Za Zhi; 2017 Mar; 42(5):982-988. PubMed ID: 28994544
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous measurement of S-warfarin, R-warfarin, S-7-hydroxywarfarin and R-7-hydroxywarfarin in human plasma by liquid chromatography-tandem mass spectrometry.
Zuo Z; Wo SK; Lo CM; Zhou L; Cheng G; You JH
J Pharm Biomed Anal; 2010 Jun; 52(2):305-10. PubMed ID: 20133101
[TBL] [Abstract][Full Text] [Related]
18. The Active Metabolite of Warfarin (3'-Hydroxywarfarin) and Correlation with INR, Warfarin and Drug Weekly Dosage in Patients under Oral Anticoagulant Therapy: A Pharmacogenetics Study.
Gemmati D; Burini F; Talarico A; Fabbri M; Bertocco C; Vigliano M; Moratelli S; Cuneo A; Serino ML; Avato FM; Tisato V; Gaudio RM
PLoS One; 2016; 11(9):e0162084. PubMed ID: 27606428
[TBL] [Abstract][Full Text] [Related]
19. Effects of torsemide on pharmacodynamics and pharmacokinetics of warfarin in humans and rats.
Kim HO; Lee KE; Park HY; Lee NR; Oh BR; Chang BC; Gwak HS
J Pharm Pharmacol; 2013 Aug; 65(8):1195-203. PubMed ID: 23837587
[TBL] [Abstract][Full Text] [Related]
20. Effect of rosuvastatin on warfarin pharmacodynamics and pharmacokinetics.
Simonson SG; Martin PD; Mitchell PD; Lasseter K; Gibson G; Schneck DW
J Clin Pharmacol; 2005 Aug; 45(8):927-34. PubMed ID: 16027403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
